Company Profile

Spun out of the University of Maryland Biotechnology Institute, Omic Biosystems, Inc. has been formed to commercialize UMBI’s deuterium (2H) isobaric amine reactive tags (DiART) technology, which facilitates the characterization and quantification of large numbers of proteins in a single experiment. Such a large-scale study of proteins, known as proteomics, represents a powerful improvement over conventional protein biochemistry where either total protein concentrations, or small numbers of individual proteins, are analyzed in each assay. The DiART technology employs novel protein tagging designs coupled with advanced sample preparation methods which are used in modern mass spectrometry measurements